Dingjun Zhu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Epigenetics and DNA Methylation 6
- Circular RNAs in diseases 5
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 4
- Co-authors
- Wenlian Xie (16 shared papers)Zaosong Zheng (12 shared papers)Qiongying Lv (5 shared papers)Jinli Han (6 shared papers)Qiyu Zhong (7 shared papers)Yuhong Cai (3 shared papers)Haicheng Chen (3 shared papers)Wei Zhang (1 shared paper)
- Journals
- Tumor Biology (3 papers)The Prostate (2 papers)Oncotarget (2 papers)BMC Urology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Dingjun Zhu
40 papers receiving 928 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 343
- Molecular Biology 516
- Immunology 118
- Oncology 143
- Pulmonary and Respiratory Medicine 139
Countries citing papers authored by Dingjun Zhu
This map shows the geographic impact of Dingjun Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingjun Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingjun Zhu more than expected).
Fields of papers citing papers by Dingjun Zhu
This network shows the impact of papers produced by Dingjun Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingjun Zhu. The network helps show where Dingjun Zhu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingjun Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 77 | |
| 2 | 2015 | 76 | |
| 3 | 2014 | 61 | |
| 4 | 2018 | 57 | |
| 5 | E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells. | 2015 | 56 |
| 6 | 2019 | 51 | |
| 7 | 2015 | 45 | |
| 8 | 2014 | 45 | |
| 9 | 2018 | 42 | |
| 10 | 2021 | 41 | |
| 11 | 2021 | 33 | |
| 12 | 2013 | 30 | |
| 13 | 2019 | 28 | |
| 14 | 2020 | 28 | |
| 15 | 2016 | 28 | |
| 16 | 2016 | 21 | |
| 17 | 2013 | 20 | |
| 18 | 2021 | 19 | |
| 19 | 2015 | 19 | |
| 20 | 2018 | 17 |
About Dingjun Zhu
Dingjun Zhu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Civil and Structural Engineering, having authored 41 papers that have together received 933 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Epigenetics and DNA Methylation (6 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (3 papers), Thermal Radiation and Cooling Technologies (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (343 citations), Molecular Biology (516 citations), Immunology (118 citations), Oncology (143 citations) and Pulmonary and Respiratory Medicine (139 citations). Dingjun Zhu has collaborated with scholars based in China and United States. Frequent co-authors include Wenlian Xie, Zaosong Zheng, Qiongying Lv, Jinli Han, Qiyu Zhong, Yuhong Cai, Haicheng Chen, Wei Zhang, Mei Ye and Wei Zhang. Their work appears in journals such as Tumor Biology, The Prostate, Oncotarget, BMC Urology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.